Olympiad Research’s Tandem Diabetes Care TNDM Stock Holding History

Olympiad Research’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+13,534	New	+$236K	0.43%	86
2025 Q4	–	Sell	-16,623	Closed	-$202K	–	227
2025 Q3	$202K	Buy	+16,623	New	+$225K	0.28%	167
2022 Q2	–	Sell	-2,517	Closed	-$293K	–	356
2022 Q1	$293K	Buy	2,517 +660	+36%	+$77.1K	0.09%	202
2021 Q4	$280K	Sell	1,857 -680	-27%	-$91.8K	0.1%	178
2021 Q3	$303K	Buy	+2,537	New	+$280K	0.09%	177

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Olympiad Research's TNDM Position: Q2 2026 in Review

Olympiad Research opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 13,534 shares worth $204K. The stake represents 0.43% of the portfolio and ranks #86 among its holdings. This is a return to the name: Olympiad Research previously reported a position in TNDM as recently as Q3 2025.

Olympiad Research first reported a position in TNDM in Q3 2021 and has held it in 5 quarters since. The position peaked at $303K in Q3 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Olympiad Research held 13,534 shares of Tandem Diabetes Care worth $204K as of Q2 2026.
Tandem Diabetes Care was a new Olympiad Research position in Q2 2026.
Tandem Diabetes Care made up 0.43% of Olympiad Research's portfolio in Q2 2026, its #86 holding.
Olympiad Research first reported a position in Tandem Diabetes Care in Q3 2021 and has held it in 5 quarters since.
Olympiad Research's Tandem Diabetes Care position peaked at $303K in Q3 2021.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Olympiad Research's 13F filing for Q2 2026, filed 24 Jul 2026.